Indication
calciphylaxis
1 clinical trial
1 product
Product
INZ-701Clinical trial
The SEAPORT 1 Study: An Open-label Exploratory Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Study Participants With End-Stage Kidney Disease Undergoing HemodialysisStatus: Recruiting, Estimated PCD: 2024-08-31